Compound class:
Synthetic organic
Comment: cis-JB253 is described in [1]. The structure is based upon that of the diabetes sulfonylurea drug glimepiride. This compound is formed from trans-JB253 upon photoisomerization using blue light. This isomerization process is reversible. The molecule is active in the cis-state, increasing insulin production from pancreatic B-cells in vitro. It is postulated that this type of photoswitchable compound could in the future, allow better control of blood glucose in diabetic patients [1].
Note that the PubChem CID we link to does not specify the cis-trans state of the compound. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
1-cyclohexyl-3-{4-[(Z)-2-[4-(diethylamino)phenyl]diazen-1-yl]benzenesulfonyl}urea |
Database Links ![]() |
|
GtoPdb PubChem SID | 223366119 |
PubChem CID | 78060683 |
Search Google for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |
Search Google for chemicals with the same backbone | FCHDFDWESRUUDK |
UniChem Compound Search for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FCHDFDWESRUUDK-QPLCGJKRSA-N |